| Particulars |
| Company Name |
Glenmark Pharmaceuticals Ltd |
| Face Value |
1 |
| BSE Code |
532296 |
| Year End |
202603 |
| Full Year |
| Equity (Rs . Cr) |
28.22 |
| B.V. (Rs) |
855.70 |
| Sales (Rs . Cr) |
8,440.10 |
| NP (Rs . Cr) |
942.47 |
| NP Var% |
-47.00 |
| Div% |
500.00 |
| CPS (Rs) |
41.80 |
| EPS (Rs) |
33.40 |
| Traded Value(Rs . Lakhs) |
835.10 |
| 52 Week High |
2,537.00 |
| 52 Week Low |
1,794.00 |
| Price BSE |
2,336.00 |
| Price NSE |
2,331.00 |
| Market Capital(Rs . Cr) |
65,936.15 |
| P/C Ratio |
55.90 |
| P/E Ratio |
70.00 |
| Price Vs.BV |
2.73 |
| Latest Quarter |
| Year End |
202606 |
| Sales (Rs . Cr) |
2,342.53 |
| NP (Rs . Cr) |
546.23 |
| NP Var % |
-8.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
8,273.06 |
| OPM |
35.69 |
| NP |
1,895.02 |
| NP Var% |
-22.09 |
| EPS |
51.73 |
| PE |
45.16 |
|